Penumbra, Inc. (PEN)
NYSE: PEN · Real-Time Price · USD
322.17
+1.03 (0.32%)
Sep 4, 2026, 4:00 PM EDT - Market closed
Penumbra Employees
Penumbra had 4,700 employees as of December 31, 2025. The number of employees increased by 200 or 4.44% compared to the previous year.
Employees
4,700
Change (1Y)
200
Growth (1Y)
4.44%
Revenue / Employee
$320,186
Profits / Employee
$34,168
Market Cap
12.69B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 4,700 | 200 | 4.44% |
| Dec 31, 2024 | 4,500 | 300 | 7.14% |
| Dec 31, 2023 | 4,200 | 300 | 7.69% |
| Dec 31, 2022 | 3,900 | 100 | 2.63% |
| Dec 31, 2021 | 3,800 | 500 | 15.15% |
| Dec 31, 2020 | 3,300 | 600 | 22.22% |
| Dec 31, 2019 | 2,700 | 500 | 22.73% |
| Dec 31, 2018 | 2,200 | 500 | 29.41% |
| Dec 31, 2017 | 1,700 | 200 | 13.33% |
| Dec 31, 2016 | 1,500 | 400 | 36.36% |
| Dec 31, 2015 | 1,100 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Koninklijke Philips | 65,340 |
| GE HealthCare Technologies | 54,000 |
| STERIS | 17,937 |
| Zimmer Biomet Holdings | 17,000 |
| Smith & Nephew | 16,988 |
| Bruker | 11,085 |
| Bio-Rad Laboratories | 7,450 |
| Bio-Rad Laboratories | 7,450 |
PEN News
- 12 days ago - Incuvate files patent infringement lawsuit against Penumbra - TheFly
- 5 weeks ago - Penumbra reports Q2 EPS 88c, consensus $1.18 - TheFly
- 5 weeks ago - Penumbra, Inc. Reports Second Quarter 2026 Financial Results - PRNewsWire
- 5 weeks ago - Penumbra Earnings release: Q2 2026 - Filings
- 5 weeks ago - Penumbra Quarterly report: Q2 2026 - Filings
- 6 weeks ago - Penumbra says THUNDER study met predefined performance goal - TheFly
- 6 weeks ago - THUNDER Study Demonstrates Penumbra's THUNDERBOLT is Safe and Effective for Stroke Care - PRNewsWire
- 2 months ago - Penumbra announces the initiation of its FORWARD study - TheFly